While COVID-19 workers’ comp claims have declined in recent months, comorbidities such as hypertension and diabetes could complicate return-to-work plans for those who contract COVID-19 and other diseases with long-lasting effects, according to a white paper on the subject.
And, among other potential conclusions, the pandemic has highlighted the need for early intervention in claims that could include substantial lost time and high treatment costs, according to “The Impact of COVID-19 Comorbidities on Return to Work,” published by ODG by MCG.
“Inadequate comorbidity m...
Comments